Company news
Helix BioPharma Corp. news in 2022
Helix BioPharma Corp.'s news releases, calls and decks from 2022, newest first.
Helix BioPharma Corp. Announces Fiscal 2023 First Quarter Results
December 14, 2022
Helix Biopharma Corp. Announces Board & Management Changes
December 8, 2022
Helix Biopharma Corp. Closes Private Placement of CAD $4.62 Million
November 3, 2022
HELIX BIOPHARMA CORP. Announces Fiscal 2022 Year-End Results
November 1, 2022
Helix BioPharma Corp. Appoints Dr. Frank Gary Renshaw as Chief Medical Officer
October 3, 2022
Helix Biopharma Corp. Appoints Gabrielle M Siegers as the Head of Research & Development
September 1, 2022
Helix Biopharma Corp. Announces Conclusion of Funding Agreement with Lind Global Macro Fund LP
August 30, 2022
Helix BioPharma Corp. Announces Scientific Collaboration with University Hospital Tuebingen
August 9, 2022
Jerzy Wilczewski Announces Acquisition of Common Shares of Helix Biopharma Corp.
April 22, 2022
Helix Biopharma Corp. Closes Private Placement
April 21, 2022
Helix Biopharma Corp. Announces Appointment of Permanent CEO and Independent Board Members
April 18, 2022
Helix Biopharma Corp. Announces Extension of Early Warrant Exercise Incentive Program and Receipt of Private Placement Subscription
April 13, 2022
Helix Announces Board Resignation
April 7, 2022
Helix Biopharma Corp. Announces Management and Board Changes
March 22, 2022
Helix Biopharma Corp. Announces Fiscal 2022 Second Quarter Results
March 16, 2022
Helix Biopharma Corp. Announces Unexpected Passing of Interim CEO and Chairman of the Board
March 16, 2022
CORRECTION: Helix Biopharma Corp. Closes Private Placement and Announces Early Warrant Exercise Incentive Program and Extension of Warrant Exercise Period
March 11, 2022
Helix Biopharma Corp. Closes Private Placement and Announces Early Warrant Exercise Incentive Program and Extension of Warrant Exercise Period
March 11, 2022
Helix BioPharma Corp. Reports Voting Results and Appointment of New Board Director
January 28, 2022